How to Stop Overthinking: 9 Cognitive Science Methods That Actually Work

/// AUDIO TRANSMISSION · EN

Listen to this transmission · 2-host podcast version

0:00 / 13:20

/// AUDIO TRANSMISSION · ES

Listen to this transmission · 2-host podcast version

0:00 / 13:40

In the summer of 1987, Daniel Wegner — then a social psychologist at Trinity University — asked a room of undergraduates to do nothing for five minutes. One thing only: don't think about a white bear. Ring a bell every time the bear appeared anyway. The bell rang, on average, every 45 seconds.

That is the official discovery the self-help industry has spent forty years pretending didn't happen.

Because the prescription you've been handed for overthinking — just stop, distract yourself, push the thought away — has a peer-reviewed name. It's called thought suppression. And the data tells a different story than the prescription suggests.

What does the science actually say about stopping overthinking?

Why does telling yourself to stop overthinking make it worse?

Wegner's 1987 paper, "Paradoxical effects of thought suppression," published in the Journal of Personality and Social Psychology (53:5–13), did three things at once. It documented the immediate effect — suppressed thoughts intrude during the suppression period. It documented the rebound — suppressed thoughts appear at higher frequency after the suppression period ends. And it gave the field a mechanism: ironic process theory.

The mechanism is mechanical. To suppress a thought, your brain runs two processes: an operating process that pursues distraction, and a monitoring process that scans for the forbidden thought to confirm you're still suppressing. The monitor is the problem. It keeps the thought active in working memory, which is exactly the opposite of forgetting it.

Fourteen years later, Abramowitz, Tolin and Street (2001) ran a meta-analysis on 28 controlled studies of thought suppression. The pooled effect was modest in the immediate-suppression phase, but the rebound effect — suppression making the thought come back stronger — was robust across study designs.

Their conclusion in Clinical Psychology Review (21:683–703): suppression is contraindicated for clinical anxiety, intrusive thoughts, and trauma-related cognition. Telling a person with PTSD not to think about the trauma makes intrusion worse. Telling a person with OCD not to think the thought makes the thought louder. Telling a person who is overthinking to stop thinking makes the thinking accelerate.

The advice you've been given is the intervention that has the most evidence against it.

What is rumination, and how is it different from problem-solving?

The word overthinking is folk vocabulary. The clinical term is rumination — repetitive, abstract, evaluative thinking about the causes and meanings of negative emotion. Susan Nolen-Hoeksema, who built the field at Stanford and Yale, distinguished rumination from problem-solving on a single axis: concrete versus abstract. Problem-solving asks "what is the next thing to do?" Rumination asks "why is this happening to me?"

Ehring and Watkins (2008) widened this in International Journal of Cognitive Therapy (1:192–205) into the Repetitive Negative Thinking model — a transdiagnostic process underlying depression, generalized anxiety, social anxiety, insomnia, OCD, and PTSD. The pattern is the same across diagnoses: abstract, evaluative, recursive, focused on uncontrollable past or hypothetical future.

This matters operationally. If your thinking is concrete and ends in an action, it isn't overthinking. If it is abstract and recurses, the question to ask is not "how do I stop?" but "which evidence-based protocol fits this pattern?" Nine answers exist. None of them are try harder.

What is cognitive defusion and why does it outperform suppression?

Steven Hayes at the University of Nevada, Reno developed Acceptance and Commitment Therapy (ACT) in the 1990s on a single anti-suppression premise: stop fighting the thought, change your relationship to it. The technical term is cognitive defusion — observing a thought as a thought, rather than as a fact about the world.

The earliest published clinical RCT was Bach and Hayes (2002), Journal of Consulting and Clinical Psychology (70:1129–1139). Eighty patients hospitalized for psychosis received either standard care or four sessions of ACT. The ACT group had half the rehospitalization rate at four-month follow-up. The intervention was four sessions.

The 2015 meta-analysis by A-Tjak, Davis, Morina, Powers, Smits, and Emmelkamp, in Psychotherapy and Psychosomatics (84:30–36), aggregated 39 randomized trials of ACT covering anxiety, depression, addiction, somatic conditions, and chronic pain. Pooled effect size at post-treatment was Hedges' g = 0.57 versus waitlist controls — a clinically meaningful effect by any standard.

The defusion mechanic is operationalizable in seconds. The thought "I am going to fail this presentation" becomes "I am having the thought that I am going to fail this presentation." The reframe doesn't argue with the thought. It removes the thought from the position of being the thinker.

What is scheduled worry time, and why does it work?

The intervention was first published by Borkovec, Wilkinson, Folensbee and Lerman (1983), Behaviour Research and Therapy (21:247–251), at Penn State. The protocol is mechanical:

• Pick one 30-minute window each day, same place, same chair.
• During that window — and only that window — worry deliberately, with a notepad.
• Outside the window, when worry arises, write the trigger on a list and defer it to the window.
• Keep the deferral.

The mechanism is stimulus control — the same operant conditioning that anchors sleep restriction therapy for insomnia. The brain learns the chair is where worry happens; the rest of the day is where it doesn't. Six weeks of compliance produces durable reductions in trait worry.

The protocol survived modernization. It was incorporated into the Behavioral Activation manuals in the 2000s and remains a first-line intervention in clinical guidelines for generalized anxiety. Its appeal: it accepts that worry will happen and removes the demand to suppress it. The bear is allowed in the room. It just gets a scheduled appointment.

What is metacognitive therapy and what evidence supports it?

Adrian Wells at the University of Manchester proposed that the problem in chronic worry isn't what people think but their beliefs about thinking — that worrying is uncontrollable, that worrying is dangerous, that worrying is necessary for safety. His 2009 textbook Metacognitive Therapy for Anxiety and Depression (Guilford Press) systematized the model.

Two interventions sit at the center. Detached mindfulness is observation of the thought without engagement, evaluation, or suppression — closer to defusion than to traditional mindfulness meditation. Attention training technique (ATT) is a 12-minute auditory exercise in which the patient practices selective and divided attention over competing sounds; the goal is direct flexibility training of the attention system itself.

The meta-analysis by Normann, van Emmerik, and Morina (2014) in Depression and Anxiety (31:402–411) pooled 16 RCTs of metacognitive therapy across generalized anxiety disorder, depression, OCD, and PTSD. Pooled Hedges' g versus waitlist was 2.06 — among the largest effect sizes documented for any short-form psychological intervention. The effect held against active control comparisons (g = 0.97).

The effect size is large enough that the field's serious critics have focused not on whether MCT works but on whether the trials are powered for the heterogeneity they claim.

Does rumination-focused CBT have its own evidence base?

It does. Watkins, Mullan, Wingrove, Rimes, Steiner, Bathurst, Eastman, and Scott (2011) randomized 42 patients with residual depression to standard antidepressant treatment alone or antidepressant plus 12 sessions of rumination-focused CBT. The augmented group had a 50% higher remission rate at three months — published in the British Journal of Psychiatry (199:317–322).

The protocol's distinguishing feature is the abstract-versus-concrete training. Patients learn to notice when their thinking has shifted from "what specifically can I do next?" to "why do these things keep happening to me?" — and to deliberately re-anchor in the concrete. The training is taught using audio recordings of patients' own ruminations and re-scripts in concrete form.

The model directly addresses the Ehring–Watkins repetitive negative thinking framework. It treats rumination as a learned, modifiable cognitive style rather than a personality trait.

What does mindfulness-based cognitive therapy add?

The largest individual-patient-data meta-analysis in this literature is Kuyken, Warren, Taylor, Whalley, Crane, Bondolfi, Hayes, Huijbers, Ma, Schweizer, Segal, Speckens, Teasdale, Van Heeringen, Williams, Byford, Byng, and Dalgleish (2016) in JAMA Psychiatry (73:565–574). Nine trials, 1,258 patients with recurrent major depression. MBCT reduced relapse risk by 31% over 60 weeks of follow-up versus usual care, and showed comparable efficacy to maintenance antidepressant medication.

MBCT teaches a particular cognitive maneuver: noticing automatic negative thoughts as mental events, not as facts requiring response. The mechanic overlaps with ACT defusion; the population studied is different. ACT was built on anxiety and behavioral activation. MBCT was built on depression relapse prevention.

The relevance to overthinking: rumination is the strongest single predictor of depressive relapse documented in the literature. Reducing the meta-cognitive grip of automatic thoughts is the proximal mechanism.

Why hasn't anyone told me this before?

The honest answer is structural. The interventions in this article were developed inside the academic clinical-psychology pipeline — peer-reviewed journals, manualized protocols, RCT funding cycles. They are not what a $4 billion self-help market sells, because none of them are products. ACT is a 12-session protocol delivered by trained clinicians. Scheduled worry time is a notepad. Metacognitive therapy is two techniques you can read in a clinical manual.

The advice that filled the vacuum — clear your mind, think positive, stop overthinking — is the advice the data has had against it longest.

Hofmann, Asnaani, Vonk, Sawyer, and Fang (2012), in Cognitive Therapy and Research (36:427–440), reviewed 269 meta-analyses covering CBT and its variants across psychiatric disorders. The conclusion: CBT has the strongest empirical support of any psychological intervention class. The variants discussed in this article — ACT, MCT, RFCBT, MBCT — sit inside that family.

The information is not behind a paywall. It is behind a translation gap.

What we can say. What we can't.

We can say: thought suppression makes intrusive thoughts more frequent and more salient, across 28+ controlled studies.

We can say: nine cognitive-science interventions have head-to-head evidence — at clinically meaningful effect sizes — against active control conditions.

We can say: rumination is operationally distinct from problem-solving on a measurable axis (abstract versus concrete), and the abstract pattern is treatable.

We can't say: which of the nine interventions is best for your specific overthinking pattern. The trials compare interventions to controls, not to each other in head-to-head matchups powered for individual differences.

We can't say: that any of these protocols replace work with a clinician for severe rumination, OCD, PTSD, or depression. The evidence base is built on protocols delivered by trained therapists.

We can say: none of them ask you to just stop thinking about it.

If "just don't think about it" makes it worse, what should you actually do tonight?

Pick one method from the list above. Run it for two weeks. Keep a simple log: number of intrusions per day, severity 1-10. If the count goes down, keep going. If it doesn't, switch methods. Your data, not the influencer's, decides.

The white bear is going to keep showing up. The question was never how to stop the bear from arriving. It was whether you'd been given the right instructions for what to do when it does.

So: have you?

---

Overthinking is one entry point into the larger evidence map of mental-work protocols. For the related interventions tested in randomized trials: magnesium for sleep, vagus nerve exercises, and the natural anxiety remedies that actually replicate. For the methodology behind every claim in this archive, see how Black Swan researches and editorial standards.

Sources

• Wegner, D. M., Schneider, D. J., Carter, S. R., White, T. L. (1987). Paradoxical effects of thought suppression. Journal of Personality and Social Psychology, 53(1):5–13.
• Abramowitz, J. S., Tolin, D. F., Street, G. P. (2001). Paradoxical effects of thought suppression: A meta-analysis of controlled studies. Clinical Psychology Review, 21(5):683–703. PubMed 11434226.
• Bach, P., Hayes, S. C. (2002). The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 70(5):1129–1139. PubMed 12404915.
• A-Tjak, J. G. L., Davis, M. L., Morina, N., Powers, M. B., Smits, J. A. J., Emmelkamp, P. M. G. (2015). A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychotherapy and Psychosomatics, 84(1):30–36. PubMed 25547522.
• Borkovec, T. D., Wilkinson, L., Folensbee, R., Lerman, C. (1983). Stimulus control applications to the treatment of worry. Behaviour Research and Therapy, 21(3):247–251. PubMed 6615383.
• Wells, A. (2009). Metacognitive Therapy for Anxiety and Depression. New York: Guilford Press.
• Normann, N., van Emmerik, A. A. P., Morina, N. (2014). The efficacy of metacognitive therapy for anxiety and depression: A meta-analytic review. Depression and Anxiety, 31(5):402–411. PubMed 24677603.
• Watkins, E. R., Mullan, E., Wingrove, J., Rimes, K., Steiner, H., Bathurst, N., Eastman, R., Scott, J. (2011). Rumination-focused cognitive-behavioural therapy for residual depression: Phase II randomised controlled trial. British Journal of Psychiatry, 199(4):317–322. PubMed 21778171.
• Ehring, T., Watkins, E. R. (2008). Repetitive negative thinking as a transdiagnostic process. International Journal of Cognitive Therapy, 1(3):192–205.
• Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5):427–440.
• Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., Huijbers, M., Ma, H., Schweizer, S., Segal, Z., Speckens, A., Teasdale, J. D., Van Heeringen, K., Williams, M., Byford, S., Byng, R., Dalgleish, T. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: An individual patient data meta-analysis from randomized trials. JAMA Psychiatry, 73(6):565–574. PubMed 27119968.
• Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. Journal of Abnormal Psychology, 109(3):504–511.

---

Related research in this cluster

• ADHD natural treatments — what actually has RCT evidence — 60+ RCTs ranked by evidence quality — what works, what doesn't
• Anxiety natural remedies — RCT-graded evidence — Ashwagandha, magnesium, breathing, exposure — what the trials actually show
• Magnesium for sleep — 60+ studies on form, dose, timing — Glycinate vs threonate vs citrate; the form matters more than marketing admits
• Vagus nerve exercises — HRV-based evidence — Which exercises actually move HRV in controlled trials